An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use

Summary

The purpose of this study is to evaluate the efficacy of re-treatment with etanercept 50mg subcutaneous injections twice weekly for 12 weeks in subjects who have previously been treated etanercept and efficacy diminished.

Timeline

Start

2010-04

Primary completion

2010-12

Completion

2010-12

Drugs

Indications